What is ELAN's five-year median EV/EBITDA?

14.5x. Half of ELAN's weekly readings over the last five years were higher and half were lower. This page has 401 weekly readings, from Feb 18, 2019 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares ELAN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Elanco Animal Health Inc (ELAN) valuation history

Health Care

$22.52

Latest weekly close · Market cap $11.4B

As of Oct 24, 2026

ELAN's EV/EBITDA is unavailable because recent financial data is missing.

No EV/EBITDA chart for ELAN right now

ELAN has no current EV/EBITDA reading to compare with its history.

See ELAN's P/S history

EV/EBITDA

n/anot ranked

No EV/EBITDA rank: recent financial data is missing.

Growth, last 12 months vs the year before

Revenue: +12%accelerating
EPS: n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

ELAN EV/EBITDA at each year-end
Year-end	EV/EBITDA	5-year percentile
Dec 29, 2025	n/a	Too little history
Dec 30, 2024	7.4×	1
Dec 25, 2023	n/a	Too little history
Dec 26, 2022	14.1×	2
Dec 27, 2021	81.7×	58
Dec 28, 2020	153.6×	98
Dec 30, 2019	27.7×	Too little history

Health Care peers on EV/EBITDA

Each percentile compares a stock with its own last five years.

Compare ELAN with peers

Health Care peers of ELAN on EV/EBITDA
Stock	EV/EBITDA	Versus its own history	5-year percentile
AXSMAxsome Therapeutics Inc	n/a	Not ranked	n/a, not ranked
BMYBristol Myers Squibb	9.6×	Within its usual range	45
CORTCorcept Therapeutics Inc	n/a	Not ranked	n/a, not ranked
JAZZJazz Pharmaceuticals PLC	10.9×	Below its usual range	29
JNJJohnson & Johnson	25.5×	Historically high	100

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on ELAN

No articles about ELAN yet. How valuation percentiles work

Loading peers and related research…

About this history

What is ELAN's current EV/EBITDA?: ELAN's EV/EBITDA is unavailable because recent financial data is missing.
What is ELAN's five-year median EV/EBITDA?: 14.5x. Half of ELAN's weekly readings over the last five years were higher and half were lower. This page has 401 weekly readings, from Feb 18, 2019 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares ELAN only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.